ATC code H04
| ATC code H: Systemic hormonal preparations, excluding sex hormones and insulins |
|---|
|
| Other ATC codes |
ATC code H04 Pancreatic hormones is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup H04 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.[4]
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH04.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
H04A Glycogenolytic hormones
[edit]H04AA Glycogenolytic hormones
[edit]- H04AA01 Glucagon
- H04AA02 Dasiglucagon
References
[edit]- ^ "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- ^ World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- ^ "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- ^ "ATC/DDD Index 2022: code H04". WHO Collaborating Centre for Drug Statistics Methodology.
- ^ "ATCvet Index 2022: code QH04". WHO Collaborating Centre for Drug Statistics Methodology.
 | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |